The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
Open accessAbstract
Interleukin-10 (IL-10) is arguably the most potent anti-inflammatory cytokine. It is produced by almost all the innate and adaptive immune cells. These cells also serve as its targets, indicating that IL-10 secretion and action is highly regulated and perhaps compartmentalized. Consistent with this notion, various efforts directed at systemic administration of IL-10 to modulate autoimmune diseases (type 1 diabetes, multiple sclerosis, rheumatoid arthritis, psoriasis) have produced conflicting and largely inconsequential effects. On the other hand, IL-10 can promote humoral immune responses, enhancing class II expression on B cells and inducing immunoglobulin (Ig) production. Consequently, the high IL-10 level in systemic lupus erythematosus (SLE) patients is considered pathogenic and its blockade ameliorates the disease. In this perspective, we review preclinical findings and results of recent clinical studies using exogenous IL-10 to treat the aforementioned autoimmune diseases. In addition, given the limited success of IL-10 supplementation, we suggest that future studies should be expanded beyond modulating the delivery modes to include developing new strategies to protect and replenish the endogenous sources of IL-10. As an example, we provide evidence that aberrant Fas-mediated deletion of IL-10-producing B cells subverts the immunoregulatory role of IL-10 in autoimmune diabetes and that modulation of the Fas pathway preserves the IL-10-producing B cells and completely protects NOD mice from developing the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Pathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
Immune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Lisnevskaia, L., Murphy, G., & Isenberg, D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60128-8 · Cited by 752
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J., & Bar-Or, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 653
Kennedy, M. K., Torrance, D. S., Picha, K. S., & Mohler, K. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.7.2496 · Cited by 618
de Waal Malefyt, R., Yssel, H., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4754 · Cited by 603
the IBSEN study group, Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S., Albrecht, M., Nothnagel, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.221 · Cited by 591
Shouval, D. S., Biswas, A., Goettel, J. A., McCann, K., Conaway, E., Redhu, N. S., Mascanfroni, I. D., Al Adham, Z., Lavoie, S., Ibourk, M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.011 · Cited by 584
Dendritic cells and cytokines in human inflammatory and autoimmune diseases
BLANCO, P., PALUCKA, A., PASCUAL, V, & BANCHEREAU, J. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.004 · Cited by 566
Epidemiology of inflammatory bowel disease
Loftus, E. V., & Sandborn, W. J. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00002-4 · Cited by 542
Llorente, L., Zou, W., Levy, Y., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Morel-Fourrier, B., Brouet, J. C., Alarcon-Segovia, D., Galanaud, P., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.839 · Cited by 541
Geginat, J., Sallusto, F., & Lanzavecchia, A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1711 · Cited by 533
Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 532
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1517 · Cited by 529
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
Bar‐Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21363 · Cited by 527
Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526 · cited 1×
“Elevated levels of TNFα fuel secretion of other cytokines, including IL-6, leading to a persistent inflammation and joint destruction [75].”
BackgroundFedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Interleukin 10: a novel stimulatory factor for mast cells and their progenitors.
Thompson-Snipes, L., Dhar, V, Bond, M. W., Mosmann, T. R., Moore, K. W., & Rennick, D. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.507 · Cited by 495
Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1625 · Cited by 475
Llorente, L., Richaud-Patin, Y., García-Padilla, C., Claret, E., Jakez-Ocampo, J., Cardiel, M. H., Alcocer-Varela, J., Grangeot-Keros, L., Alarcón-Segovia, D., Wijdenes, J., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1790::aid-anr15>3.0.co;2-2 · Cited by 461
Mechanisms maintaining peripheral tolerance
Mueller, D. L. (2010) · Nature Immunology · doi:10.1038/ni.1817 · Cited by 461
DiLillo, D. J., Matsushita, T., & Tedder, T. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05137.x · Cited by 432
Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse
Pennline, K. J., Roque-Gaffney, E., & Monahan, M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1068 · Cited by 424
Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., & Dinarello, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5492 · Cited by 418
Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., Volk, H. D., & Döcke, W. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1476 · Cited by 415
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Sartor, R. B. (1997) · PubMed · Cited by 391
Ito, S., Ansari, P., Sakatsume, M., Dickensheets, H., Vazquez, N., Donnelly, R. P., Larner, A. C., & Finbloom, D. S. (1999) · Blood · doi:10.1182/blood.v93.5.1456 · Cited by 389
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
Schreiber, S., Heinig, T., Thiele, H.-G., & Raedler, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90692-4 · Cited by 372
Interleukin‐10 prevents experimental allergic encephalomyelitis in rats
Rott, O., Fleischer, B., & Cash, E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240629 · Cited by 367
IL-10, a novel growth cofactor for mature and immature T cells.
MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., & Zlotnik, A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4167 · Cited by 360
Expression cloning and characterization of a human IL-10 receptor.
Liu, Y., Wei, S. H., Ho, A. S. Y., de Waal Malefyt, R., & Moore, K. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1821 · Cited by 321
Llorente, L., Richaud‐Patin, Y., Fior, R., Alcocer‐Varela, J., Wijdenes, J., Fourrier, B. M., Galanaud, P., & Emilie, D. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371114 · Cited by 313
Koppelman, B., Neefjes, J. J., de Vries, J. E., & de Waal Malefyt, R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80404-5 · Cited by 307
Wogensen, L., Lee, M. S., & Sarvetnick, N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1379 · Cited by 294
Hagiwara, E., Gourley, M. F., Lee, S., & Klinman, D. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390305 · Cited by 287
Interferon gamma inhibits interleukin 10 production by monocytes.
Chomarat, P., Rissoan, M. C., Banchereau, J., & Miossec, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.523 · Cited by 287
B cells and multiple sclerosis
Franciotta, D., Salvetti, M., Lolli, F., Serafini, B., & Aloisi, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70192-3 · Cited by 287
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Gröndal, G., Gunnarsson, I., Rönnelid, J., Rogberg, S., Klareskog, L., & Lundberg, I. E. (2000) · PubMed · Cited by 287
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
Houssiau, F., Lefebvre, C., Vanden Berghe, M., Lambert, M., Devogelaer, J.-P., & Renauld, J.-C. (1995) · Lupus · doi:10.1177/096120339500400510 · Cited by 281
Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., & Kunkel, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117993 · Cited by 270
Elevated interleukin-10 levels in patients with rheumatoid arthritis: ELEVATED IL-10 RA PATIENTS
Cush, J. J., Splawski, J. B., Thomas, R., Mcfarlin, J. E., Schulze-Koops, H., Davis, L. S., Fujita, K., & Lipsky, P. E. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380115 · Cited by 249
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
Colombel, J.-F., Rutgeerts, P., Malchow, H., Jacyna, M., Nielsen, O. H., Rask-Madsen, J., Van Deventer, S., Ferguson, A., Desreumaux, P., Forbes, A., et al. (2001) · Gut · doi:10.1136/gut.49.1.42 · Cited by 240
Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis
Rudick, R. A., Ransohoff, R. M., Peppler, R., Medendorp, S. V., Lehmann, P., & Alam, J. (1996) · Annals of Neurology · doi:10.1002/ana.410400412 · Cited by 237
IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro
Bouaziz, J., Calbo, S., Maho‐Vaillant, M., Saussine, A., Bagot, M., Bensussan, A., & Musette, P. (2010) · European Journal of Immunology · doi:10.1002/eji.201040673 · Cited by 237
Horwitz, D. A., Gray, J. D., Behrendsen, S. C., Kubin, M. Z., Rengaraju, M., Ohtsuka, K., & Trinchieri, G. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199805)41:5<838::aid-art10>3.0.co;2-s · Cited by 223
The family of IL-10-related cytokines and their receptors: related, but to what extent?
Kotenko, S. V. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00012-6 · Cited by 213
Systemic but Not Local Infections Elicit Immunosuppressive IL-10 Production by Natural Killer Cells
Perona-Wright, G., Mohrs, K., Szaba, F. M., Kummer, L. W., Madan, R., Karp, C. L., Johnson, L. L., Smiley, S. T., & Mohrs, M. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.11.003 · Cited by 212
Llorente, L., Richaud‐Patín, Y., Wijdenes, J., Alcocer-Varela, J. C., Maillot, M. C., Durand–Gasselin, I., Fourrier, B. M., Galanaud, P., & Émilie, D. (1993) · PubMed · Cited by 203
Functional Characterization of Human IL-10
Spits, H., & de Waal Malefyt, R. (1992) · International Archives of Allergy and Immunology · doi:10.1159/000236329 · Cited by 198
Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies
Song, Y. W., & Kang, E. H. (2010) · QJM · doi:10.1093/qjmed/hcp165 · Cited by 190
Akdis, C. A., Joss, A., Akdis, M., Faith, A., & Blaser, K. (2000) · The FASEB Journal · doi:10.1096/fj.99-0874fje · Cited by 182
Regulatory B cells in autoimmunity: developments and controversies
Mauri, C., & Blair, P. A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.140 · Cited by 181
Sattler, S., Ling, G.-S., Xu, D., Hussaarts, L., Romaine, A., Zhao, H., Fossati-Jimack, L., Malik, T., Cook, H. T., Botto, M., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.032 · Cited by 173
Production of IL-10 by Human Natural Killer Cells Stimulated with IL-2 and/or IL-12
Mehrotra, P. T., Donnelly, R. P., Wong, S., Kanegane, H., Geremew, A., Mostowski, H. S., Furuke, K., Siegel, J. P., & Bloom, E. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2637 · Cited by 172
Interleukin 10 Treatment of Psoriasis: Clinical Results of a Phase 2 Trial
Asadullah, K., Döcke, W. D., Ebeling, M., Friedrich, M., Belbe, G., Audring, H., Volk, H., & Sterry, W. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.2.187 · Cited by 170
Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes
Thibodeau, J., Bourgeois‐Daigneault, M., Huppé, G., Tremblay, J., Aumont, A., Houde, M., Bartee, E., Brunet, A., Gauvreau, M., de Gassart, A., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737902 · Cited by 166
IL-10 fails to abrogate experimental autoimmune encephalomyelitis
Cannella, B., Gao, Y. L., Brosnan, C., & Raine, C. S. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960915)45:6<735::aid-jnr10>3.0.co;2-v · Cited by 165
Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD)
KUCHARZIK, T., STOLL, R., LÜGERING, N., & DOMSCHKE, W. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03721.x · Cited by 162
Characterization of interleukin-10 receptors on human and mouse cells.
Tan, J. C., Indelicato, S. R., Narula, S. K., Zavodny, P. J., & Chou, C. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36892-9 · Cited by 161
Issazadeh, S., Mustafa, M., Ljungdahl, Å., Höjeberg, B., Dagerlind, Å., Elde, R., & Olsson, T. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400503 · Cited by 158
IL-10 Is an Autocrine Inhibitor of Human Placental Cytotrophoblast MMP-9 Production and Invasion
Roth, I., & Fisher, S. J. (1999) · Developmental Biology · doi:10.1006/dbio.1998.9122 · Cited by 154
Yoon, S. I., Logsdon, N. J., Sheikh, F. G., Donnelly, R. P., & Walter, M. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606791200 · Cited by 149
Gasim, S., El-Hassan, A. M., Khalil, E. A. G., Ismail, A., Kadaru, A. M. Y., Kharazmi, A., & Theander, T. G. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00468.x · Cited by 143
Jacob, S. E., Nassiri, M., Kerdel, F. A., & Vincek, V. (2003) · Mediators of Inflammation · doi:10.1080/09629350310001619753 · Cited by 141
Zheng, X. X., Steele, A. W., Hancock, W. W., Stevens, A. C., Nickerson, P. W., Roy‐Chaudhury, P., Tian, Y., & Strom, T. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4507 · Cited by 132
Llorente, L., Richaud‐Patín, Y., Couderc, J., Alarcón-Segovia, D., Ruiz‐Soto, R., Castillejos, N. A., Alcocer-Varela, J. C., Granados, J., Bahena, S., Galanaud, P., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400810 · Cited by 132
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers*
Huhn, R. D., Radwanski, E., Gallo, J., Affrime, M. B., Sabo, R., Gonyo, G., Monge, A., & Cutler, D. L. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90065-5 · Cited by 131
Lampropoulou, V., Calderon‐Gomez, E., Roch, T., Neves, P., Shen, P., Stervbo, U., Boudinot, P., Anderton, S. M., & Fillatreau, S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00855.x · Cited by 130
Cutting Edge: CD4+CD25+ Regulatory T Cells Impaired for Intestinal Homing Can Prevent Colitis
Denning, T. L., Kim, G., & Kronenberg, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7487 · Cited by 128
Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells
Chang, J., Kunkel, S. L., & Chang, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905815106 · Cited by 125
Reich, K., Blaschke, V., Maurer, C., Lippert, U., Neumann, C. R., Garbe, C., Middel, P., & Westphal, G. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01248.x · Cited by 124
Moritani, M., Yoshimoto, K., Ii, S., Kondo, M., Iwahana, H., Yamaoka, T., Sano, T., Nakano, N., Kikutani, H., & Itakura, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118986 · Cited by 122
Lee, M. S., Wogensen, L., Shizuru, J. A., Oldstone, M. B. A., & Sarvetnick, N. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117092 · Cited by 119
Wang, X., Chen, M., Wandinger, K.-P., Williams, G. J., & Dhib-Jalbut, S. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.548 · Cited by 116
Is there an interaction between interleukin-10 and interleukin-22?
Wolk, K., Witte, E., Reineke, U., Witte, K., Friedrich, M., Sterry, W., Asadullah, K., Volk, H., & Sabat, R. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364144 · Cited by 109
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
Ragheb, S., Li, Y., Simon, K. W., VanHaerents, S. A., Galimberti, D., Riz, M. A. D., Fenoglio, C., Scarpini, E. A., & Lisak, R. P. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511398887 · Cited by 109
IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.
Lee, M. S., Mueller, R., Wicker, L. S., Peterson, L. B., & Sarvetnick, N. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2663 · Cited by 105
Persson, S. T., Mikulowska, A., Narula, S. K., O’Garra, A., & Holmdahl, R. (1996) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1996.d01-355.x · Cited by 103
Structure and Mechanism of Receptor Sharing by the IL-10R2 Common Chain
Yoon, S., Jones, B. C., Logsdon, N. J., Harris, B. D., Deshpande, A. A., Radaeva, S., Halloran, B., Gao, B., & Walter, M. R. (2010) · Structure · doi:10.1016/j.str.2010.02.009 · Cited by 101
Porrini, A. M. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00070-i · Cited by 101
Expression of IL-10 receptors on epithelial cells from the murine small and large intestine
Denning, T. L., Campbell, N. A., Song, F., Garofalo, R. P., Klimpel, G. R., Reyes, V. E., & Ernst, P. B. (2000) · International Immunology · doi:10.1093/intimm/12.2.133 · Cited by 98
Stern, R. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05257-4 · Cited by 94
Rhodes, K. A., Andrew, E. M., Newton, D. J., Tramonti, D., & Carding, S. R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838354 · Cited by 89
Lutfalla, G., Gardiner, K., & Uzé, G. (1993) · Genomics · doi:10.1006/geno.1993.1199 · Cited by 89
On the protein-protein diffusional encounter complex
Gabdoulline, R. R., & Wade, R. C. (1999) · Journal of Molecular Recognition · doi:10.1002/(sici)1099-1352(199907/08)12:4<242::aid-jmr461>3.0.co;2-1 · Cited by 89
Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis
Hirotani, M., Niino, M., Fukazawa, T., Kikuchi, S., Yabe, I., Hamada, S., Tajima, Y., & Sasaki, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.012 · Cited by 86
Interleukin‐10 Response Abnormalities in Systemic Lupus Erythematosus
Mongan, A. E., Ramdahin, S., & Warrington, R. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-140.x · Cited by 77
Nagelkerken, L. M. (1997) · International Immunology · doi:10.1093/intimm/9.9.1243 · Cited by 73
Recombinant human interleukin 10 for induction of remission in Crohn's disease
Buruiana, F. E., Solà, I., & Alonso‐Coello, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005109.pub3 · Cited by 73
Mitsuyama, K., Tomiyasu, N., Takaki, K., Masuda, J., Yamasaki, H., Kuwaki, K., Takeda, T., Kitazaki, S., Tsuruta, O., & Sata, M. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/26875 · Cited by 69
Roberti, M. L., Ricottini, L., Capponi, A., Sclauzero, E., Vicenti, P., Fiorentini, E., Savoia, C., Scornavacca, G., Brazioli, D., Gaio, L., et al. (2014) · PubMed · Cited by 67
Al‐Janadi, M., Al-Dalaan, A., Al-Balla, S. R., Al-Humaidi, M. A., & Raziuddin, S. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01541225 · Cited by 66
Wang, A. H., Lam, W.-J., Han, D.-Y., Ding, Y., Hu, R., Fraser, A. G., Ferguson, L. R., & Morgan, A. R. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.02.014 · Cited by 66
Defective IL-10 production in severe phenotypes of Crohn’s disease
Correa, I., Veny, M., Esteller, M., Piqué, J. M., Yagüe, J., Panés, J., & Salas, A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1108698 · Cited by 66
Characterization of Recombinant Extracellular Domain of Human Interleukin-10 Receptor
Tan, J. C., Braun, S., Rong, H., DiGiacomo, R., Dolphin, E., Baldwin, S., Narula, S. K., Zavodny, P. J., & Chou, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12906 · Cited by 63
Thompson, W. S., Pękalski, M. Ł., Simons, H. Z., Smyth, D. J., Dopico, X. C., Guo, H., Guy, C., Dunger, D. B., Arif, S., Peakman, M., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12362 · Cited by 59
Endogenous suppression of mast cell development and survival by IL-4 and IL-10
Speiran, K., Bailey, D. P., Fernando, J. F. A., Macey, M., Barnstein, B. O., Kolawole, E. M., Curley, D., Watowich, S. S., Murray, P. J., Oskeritzian, C. A., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708448 · Cited by 55
Schröder, M., Meisel, C., Buhl, K., Profanter, N., Sievert, N., Volk, H., & Grütz, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5260 · Cited by 54
Lauwerys, B. R., Garot, N., Renauld, J., & Houssiau, F. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1976::aid-anr8>3.0.co;2-v · Cited by 51
Dagvadorj, J., Naiki, Y., Tumurkhuu, G., Hassan, F., Islam, S., Koide, N., Mori, I., Yoshida, T., & Yokochi, T. (2008) · Innate Immunity · doi:10.1177/1753425908089618 · Cited by 47
Interferon beta-1b increases interleukin-10 in a model of T cell–microglia interaction
Chabot, S., & Yong, V. W. (2000) · Neurology · doi:10.1212/wnl.55.10.1497 · Cited by 43
Ishizuka, K., Sugimura, K., Homma, T., Matsuzawa, J., Mochizuki, T., Kobayashi, M., Suzuki, K., Otsuka, K., Tashiro, K., Yamaguchi, O., et al. (2001) · Digestion · doi:10.1159/000051906 · Cited by 40
Mussi, A., Bonifati, C., Carducci, M., Viola, M., Tomaselli, R., Sacerdoti, G., Fazio, M., & Ameglio, F. (1994) · PubMed · Cited by 37
Balasa, B., Gunst, K. V., Jung, N., et al. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1658 · Cited by 34
Circulating Cytokines Reflect Mucosal Inflammatory Status in Patients with Crohn’s Disease
Ljuca, F., Gegic, A., Salkic, N. N., & Pavlović-Čalić, N. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1016-9 · Cited by 32
Xiao, Z., Mohamood, A. S., Uddin, S., Gutfreund, R., Nakata, C., Marshall, A. F., Kimura, H. J., Caturegli, P., Womer, K. L., Huang, Y., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.016 · Cited by 30
Self-citationThe human interleukin-10 receptor gene maps to chromosome 11q23.3
Taniyama, T., Takai, S., Miyazaki, E., Fukumura, R., Sato, J., Kobayashi, Y., Hírakawa, T., Moore, K., & Yamada, K. (1995) · Human Genetics · doi:10.1007/bf00225083 · Cited by 20
Selective DNA-Binding Activity of Interleukin-10-Stimulated STAT Molecules in Human Monocytes
Yamaoka, K., Otsuka, T., Niiro, H., Nakashima, H., Tanaka, Y., Nagano, S., Ogami, E., Niho, Y., Hamasaki, N., & Izuhara, K. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313839 · Cited by 18
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Skeletal Muscle as Potential Central Link between Sarcopenia and Immune Senescence
Nelke, C., Dziewas, R., Minnerup, J., Meuth, S. G., & Ruck, T. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.10.034 · Cited by 437
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity
Minciullo, P. L., Catalano, A., Mandraffino, G., Casciaro, M., Crucitti, A., Maltese, G., Morabito, N., Lasco, A., Gangemi, S., & Basile, G. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0377-3 · Cited by 433
The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis
Steen, E. H., Wang, X., Balaji, S., Butte, M. J., Bollyky, P. L., & Keswani, S. G. (2020) · Advances in Wound Care · doi:10.1089/wound.2019.1032 · Cited by 433
Balancing the immune response in the brain: IL-10 and its regulation
Lobo-Silva, D., Carriche, G. M., Castro, A. G., Roque, S., & Saraiva, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0763-8 · Cited by 429
Metadata
- Authors
- Saxena, A., Khosraviani, S., Noel, S., Mohan, D., Donner, T., & Hamad, A. R. A.
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 74
- Issue
- 1
- Pages
- 27-34
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W2047543986
- Cited by
- 306
- References
- 127
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.